.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Argus Health
Harvard Business School
Merck
Federal Trade Commission
Teva
Farmers Insurance
US Army
Cerilliant

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040204

« Back to Dashboard

NDA 040204 describes DICYCLOMINE HYDROCHLORIDE, which is a drug marketed by Hikma Pharms, Lannett, Mylan, Pioneer Pharms, Sun Pharm Industries, Watson Labs, Luitpold Pharms Inc, Alpharma Us Pharms, Mikart, and West-ward Pharms Int, and is included in nineteen NDAs. It is available from forty-five suppliers. Additional details are available on the DICYCLOMINE HYDROCHLORIDE profile page.

The generic ingredient in DICYCLOMINE HYDROCHLORIDE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.

Summary for 040204

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 040204

Mechanism of ActionCholinergic Antagonists

Medical Subject Heading (MeSH) Categories for 040204

Suppliers and Packaging for NDA: 040204

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 040204 ANDA West-ward Pharmaceutical Corp 0143-3126 0143-3126-10 1000 CAPSULE in 1 BOTTLE, PLASTIC (0143-3126-10)
DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 040204 ANDA West-ward Pharmaceutical Corp 0143-3126 0143-3126-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0143-3126-01)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength10MG
Approval Date:Feb 28, 1997TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Merck
Cantor Fitzgerald
AstraZeneca
McKesson
Dow
Moodys
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot